Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes

Area of Science:

• Biochemistry
• Cell Biology
• Pathology

Background:

• Mitochondrial alterations are implicated in osteoarthritis (OA) pathogenesis.
• Inflammation plays a critical role in OA progression.

Purpose of the Study:

• To investigate the role of mitochondrial dysfunction in enhancing the inflammatory response of human chondrocytes to cytokines.
• To explore the underlying mechanisms involving reactive oxygen species (ROS) and NF-κB pathways.

Main Methods:

• Induced mitochondrial dysfunction using respiratory chain inhibitors (antimycin A, oligomycin).
• Stimulated human chondrocytes with inflammatory cytokines (IL-1β, TNFα).
• Assessed inflammatory markers (IL-8, COX-2, PGE2), neutrophil chemotaxis, and effects of ROS/NF-κB inhibitors and resveratrol.

Main Results:

• Mitochondrial dysfunction significantly potentiated IL-1β- and TNFα-induced expression of IL-8, COX-2, and PGE2.
• Cytokine-induced neutrophil chemotaxis was increased by mitochondrial dysfunction.
• Inhibitors of ROS and NF-κB reduced IL-8 production, while resveratrol mitigated the inflammatory response.

Conclusions:

• Mitochondrial dysfunction amplifies chondrocyte inflammatory responses to cytokines via ROS production and NF-κB activation.
• This mechanism contributes to cartilage damage and joint dysfunction in osteoarthritis.
• Targeting mitochondrial pathways may offer therapeutic strategies for OA.